NO20053557L - Fremgangsmate for produksjon av 3'-nukleosid prolegemidler. - Google Patents
Fremgangsmate for produksjon av 3'-nukleosid prolegemidler.Info
- Publication number
- NO20053557L NO20053557L NO20053557A NO20053557A NO20053557L NO 20053557 L NO20053557 L NO 20053557L NO 20053557 A NO20053557 A NO 20053557A NO 20053557 A NO20053557 A NO 20053557A NO 20053557 L NO20053557 L NO 20053557L
- Authority
- NO
- Norway
- Prior art keywords
- producing
- nucleoside prodrugs
- nucleoside
- prodrugs
- asylation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43615002P | 2002-12-23 | 2002-12-23 | |
PCT/US2003/041603 WO2004058792A1 (en) | 2002-12-23 | 2003-12-23 | Process for the production of 3'-nucleoside prodrugs |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20053557L true NO20053557L (no) | 2005-09-08 |
Family
ID=32682350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053557A NO20053557L (no) | 2002-12-23 | 2005-07-20 | Fremgangsmate for produksjon av 3'-nukleosid prolegemidler. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20040181051A1 (es) |
EP (1) | EP1575971A4 (es) |
JP (1) | JP2006514038A (es) |
KR (1) | KR20050110611A (es) |
CN (1) | CN100335492C (es) |
AU (1) | AU2003300434A1 (es) |
BR (1) | BR0316868A (es) |
CA (1) | CA2511616A1 (es) |
IL (1) | IL169314A0 (es) |
MX (1) | MXPA05006865A (es) |
NO (1) | NO20053557L (es) |
NZ (1) | NZ540913A (es) |
PL (1) | PL377608A1 (es) |
RU (1) | RU2005123395A (es) |
WO (1) | WO2004058792A1 (es) |
ZA (1) | ZA200505040B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
NZ547204A (en) | 2000-05-26 | 2008-01-31 | Idenix Cayman Ltd | Methods and compositions for treating flaviviruses and pestiviruses |
KR20050088079A (ko) | 2002-11-15 | 2005-09-01 | 이데닉스 (케이만) 리미티드 | 2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이 |
WO2004096149A2 (en) * | 2003-04-28 | 2004-11-11 | Idenix (Cayman) Limited | Industrially scalable nucleoside synthesis |
WO2005123087A2 (en) * | 2004-06-15 | 2005-12-29 | Merck & Co., Inc. | C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
WO2006050161A2 (en) | 2004-10-29 | 2006-05-11 | Biocryst Pharmaceuticals, Inc. | Therapeutic furopyrimidines and thienopyrimidines |
EP1830871A1 (en) * | 2004-12-23 | 2007-09-12 | Novartis AG | Compositions for hcv treatment |
US8802840B2 (en) | 2005-03-08 | 2014-08-12 | Biota Scientific Management Pty Ltd. | Bicyclic nucleosides and nucleotides as therapeutic agents |
US7514410B2 (en) * | 2005-03-29 | 2009-04-07 | Biocryst Pharmaceuticals, Inc. | Hepatitis C therapies |
CA2622191A1 (en) * | 2005-09-22 | 2008-03-11 | Keshab Sarma | Selective o-acylation of nucleosides |
WO2007095269A2 (en) * | 2006-02-14 | 2007-08-23 | Merck & Co., Inc. | Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
EP2004634A1 (en) | 2006-04-04 | 2008-12-24 | F.Hoffmann-La Roche Ag | 3',5'-di-o-acylated nucleosides for hcv treatment |
WO2010015637A1 (en) * | 2008-08-06 | 2010-02-11 | Novartis Ag | New antiviral modified nucleosides |
CL2009002206A1 (es) | 2008-12-23 | 2011-08-26 | Gilead Pharmasset Llc | Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales. |
NZ593648A (en) | 2008-12-23 | 2013-09-27 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
EA201100851A1 (ru) | 2008-12-23 | 2012-04-30 | Фармассет, Инк. | Аналоги нуклеозидов |
PE20120013A1 (es) * | 2009-01-09 | 2012-02-02 | Univ Cardiff | Fosforamidato derivados de guanosina compuestos nucleosidos para tratamiento de infecciones virales |
BR112012024884A2 (pt) | 2010-03-31 | 2016-10-18 | Gilead Pharmasset Llc | síntese estereosseletiva de ativos contendo fósforo |
EA037868B1 (ru) | 2016-09-07 | 2021-05-28 | Атеа Фармасьютикалс, Инк. | 2'-замещенные-n6-замещенные пуриновые нуклеотиды для лечения вызванных рнк-вирусом заболеваний |
US20220033430A1 (en) * | 2018-11-25 | 2022-02-03 | Tnt Medical Corporation | Orally active prodrug of gemcitabine |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3798209A (en) * | 1971-06-01 | 1974-03-19 | Icn Pharmaceuticals | 1,2,4-triazole nucleosides |
USRE29835E (en) * | 1971-06-01 | 1978-11-14 | Icn Pharmaceuticals | 1,2,4-Triazole nucleosides |
US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
FR2562543B1 (fr) * | 1984-04-10 | 1987-09-25 | Elf Aquitaine | Nouveaux phosphonites cycliques, leur preparation et applications |
NL8403224A (nl) * | 1984-10-24 | 1986-05-16 | Oce Andeno Bv | Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen. |
US5223263A (en) * | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
GB8719367D0 (en) * | 1987-08-15 | 1987-09-23 | Wellcome Found | Therapeutic compounds |
US5411947A (en) * | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
US5463092A (en) * | 1989-11-22 | 1995-10-31 | Vestar, Inc. | Lipid derivatives of phosphonacids for liposomal incorporation and method of use |
CA2083961A1 (en) * | 1990-05-29 | 1991-11-30 | Henk Van Den Bosch | Synthesis of glycerol di- and triphosphate derivatives |
US5627165A (en) * | 1990-06-13 | 1997-05-06 | Drug Innovation & Design, Inc. | Phosphorous prodrugs and therapeutic delivery systems using same |
US5543390A (en) * | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Covalent microparticle-drug conjugates for biological targeting |
US5149794A (en) * | 1990-11-01 | 1992-09-22 | State Of Oregon | Covalent lipid-drug conjugates for drug targeting |
US5256641A (en) * | 1990-11-01 | 1993-10-26 | State Of Oregon | Covalent polar lipid-peptide conjugates for immunological targeting |
US5543389A (en) * | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization | Covalent polar lipid-peptide conjugates for use in salves |
US5157027A (en) * | 1991-05-13 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Bisphosphonate squalene synthetase inhibitors and method |
US5554728A (en) * | 1991-07-23 | 1996-09-10 | Nexstar Pharmaceuticals, Inc. | Lipid conjugates of therapeutic peptides and protease inhibitors |
US5696277A (en) * | 1994-11-15 | 1997-12-09 | Karl Y. Hostetler | Antiviral prodrugs |
IL129126A0 (en) * | 1996-10-16 | 2000-02-17 | Icn Pharmaceuticals | Monocyclic l-nucleosides analogs and uses thereof |
US6248878B1 (en) * | 1996-12-24 | 2001-06-19 | Ribozyme Pharmaceuticals, Inc. | Nucleoside analogs |
US6472373B1 (en) * | 1997-09-21 | 2002-10-29 | Schering Corporation | Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection |
US6172046B1 (en) * | 1997-09-21 | 2001-01-09 | Schering Corporation | Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection |
BR9908270A (pt) * | 1998-02-25 | 2004-06-29 | Univ Emory | 2-fluoro-nucleosìdeos, composições farmacêuticas e seus usos |
US6312662B1 (en) * | 1998-03-06 | 2001-11-06 | Metabasis Therapeutics, Inc. | Prodrugs phosphorus-containing compounds |
PL192364B1 (pl) * | 1998-06-08 | 2006-10-31 | Hoffmann La Roche | Zastosowanie koniugatu PEG-IFN-α 2A w połączeniu z rybawiryną |
WO2001018013A1 (en) * | 1999-09-08 | 2001-03-15 | Metabasis Therapeutics, Inc. | Prodrugs for liver specific drug delivery |
US6566365B1 (en) * | 1999-11-04 | 2003-05-20 | Biochem Pharma Inc. | Method for the treatment of Flaviviridea viral infection using nucleoside analogues |
HUP0204092A3 (en) * | 1999-12-22 | 2005-02-28 | Metabasis Therapeutics Inc San | Novel bisamidate phosphononate prodrugs |
US6495677B1 (en) * | 2000-02-15 | 2002-12-17 | Kanda S. Ramasamy | Nucleoside compounds |
KR20030005197A (ko) * | 2000-02-18 | 2003-01-17 | 샤이어 바이오켐 인코포레이티드 | 뉴클레오시드유도체를 이용한 플라비바이러스 감염의 치료또는 예방 방법 |
DE60136620D1 (de) * | 2000-04-13 | 2009-01-02 | Pharmasset Inc | 3 oder 2 hydroxymethyl substituierte nucleoside derivate und ihre verwendung zur behandlung von virusinfektionen |
WO2001081359A1 (en) * | 2000-04-20 | 2001-11-01 | Schering Corporation | Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
MY164523A (en) * | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
NZ547204A (en) * | 2000-05-26 | 2008-01-31 | Idenix Cayman Ltd | Methods and compositions for treating flaviviruses and pestiviruses |
US6875751B2 (en) * | 2000-06-15 | 2005-04-05 | Idenix Pharmaceuticals, Inc. | 3′-prodrugs of 2′-deoxy-β-L-nucleosides |
US20030008841A1 (en) * | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
EP2145965A1 (en) * | 2000-10-18 | 2010-01-20 | Pharmasset, Inc. | Multiplex quantification of nucleic acids in diseased cells |
EP1326594A2 (en) * | 2000-10-18 | 2003-07-16 | Schering Corporation | Ribavirin-pegylated interferon alfa hcv combination therapy |
CN1646141B (zh) * | 2000-10-18 | 2014-06-25 | 吉利德制药有限责任公司 | 用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物 |
US7105499B2 (en) * | 2001-01-22 | 2006-09-12 | Merck & Co., Inc. | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
MXPA03006514A (es) * | 2001-01-22 | 2004-12-02 | Merck & Co Inc | Derivados de nucleosidos como inhibidores de polimerasa de acido ribonucleico viral dependiente de acido ribonucleico. |
GB0112617D0 (en) * | 2001-05-23 | 2001-07-18 | Hoffmann La Roche | Antiviral nucleoside derivatives |
GB0114286D0 (en) * | 2001-06-12 | 2001-08-01 | Hoffmann La Roche | Nucleoside Derivatives |
WO2003024461A1 (en) * | 2001-09-20 | 2003-03-27 | Schering Corporation | Hcv combination therapy |
JP2005522443A (ja) * | 2002-02-14 | 2005-07-28 | フアーマセツト・リミテツド | 改変フッ素化ヌクレオシド類似体 |
AU2003217863B9 (en) * | 2002-02-28 | 2009-10-29 | Biota Scientific Management Pty Ltd | Nucleotide mimics and their prodrugs |
US7247621B2 (en) * | 2002-04-30 | 2007-07-24 | Valeant Research & Development | Antiviral phosphonate compounds and methods therefor |
EP1501850A2 (en) * | 2002-05-06 | 2005-02-02 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis c virus infection |
PL374792A1 (en) * | 2002-06-28 | 2005-10-31 | Idenix (Cayman) Limited | 2' and 3'-nucleoside prodrugs for treating flaviviridae infections |
AU2003248748A1 (en) * | 2002-06-28 | 2004-01-19 | Idenix (Cayman) Limited | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
US7094768B2 (en) * | 2002-09-30 | 2006-08-22 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis C virus infection |
WO2004028481A2 (en) * | 2002-09-30 | 2004-04-08 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis c virus infection |
KR20050088079A (ko) * | 2002-11-15 | 2005-09-01 | 이데닉스 (케이만) 리미티드 | 2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이 |
TWI332507B (en) * | 2002-11-19 | 2010-11-01 | Hoffmann La Roche | Antiviral nucleoside derivatives |
CA2509687C (en) * | 2002-12-12 | 2012-08-14 | Idenix (Cayman) Limited | Process for the production of 2'-branched nucleosides |
-
2003
- 2003-12-23 RU RU2005123395/04A patent/RU2005123395A/ru not_active Application Discontinuation
- 2003-12-23 AU AU2003300434A patent/AU2003300434A1/en not_active Abandoned
- 2003-12-23 JP JP2004562599A patent/JP2006514038A/ja active Pending
- 2003-12-23 MX MXPA05006865A patent/MXPA05006865A/es unknown
- 2003-12-23 NZ NZ540913A patent/NZ540913A/en unknown
- 2003-12-23 WO PCT/US2003/041603 patent/WO2004058792A1/en active Application Filing
- 2003-12-23 CA CA002511616A patent/CA2511616A1/en not_active Abandoned
- 2003-12-23 PL PL377608A patent/PL377608A1/pl not_active Application Discontinuation
- 2003-12-23 EP EP03814400A patent/EP1575971A4/en not_active Withdrawn
- 2003-12-23 CN CNB2003801098204A patent/CN100335492C/zh not_active Expired - Fee Related
- 2003-12-23 BR BR0316868-9A patent/BR0316868A/pt not_active IP Right Cessation
- 2003-12-23 KR KR1020057011749A patent/KR20050110611A/ko not_active Application Discontinuation
- 2003-12-23 US US10/746,395 patent/US20040181051A1/en not_active Abandoned
-
2005
- 2005-06-21 ZA ZA200505040A patent/ZA200505040B/en unknown
- 2005-06-21 IL IL169314A patent/IL169314A0/en unknown
- 2005-07-20 NO NO20053557A patent/NO20053557L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2511616A1 (en) | 2004-07-15 |
CN100335492C (zh) | 2007-09-05 |
WO2004058792A1 (en) | 2004-07-15 |
PL377608A1 (pl) | 2006-02-06 |
KR20050110611A (ko) | 2005-11-23 |
AU2003300434A1 (en) | 2004-07-22 |
ZA200505040B (en) | 2006-04-26 |
IL169314A0 (en) | 2007-07-04 |
MXPA05006865A (es) | 2005-12-12 |
EP1575971A1 (en) | 2005-09-21 |
NZ540913A (en) | 2008-02-29 |
US20040181051A1 (en) | 2004-09-16 |
BR0316868A (pt) | 2005-10-25 |
RU2005123395A (ru) | 2006-01-27 |
CN1751058A (zh) | 2006-03-22 |
JP2006514038A (ja) | 2006-04-27 |
EP1575971A4 (en) | 2008-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053557L (no) | Fremgangsmate for produksjon av 3'-nukleosid prolegemidler. | |
UY26569A1 (es) | Derivados de nicotinamida benzocondensada - heterocíclilo útiles como inhibidores selectivos de las isozimas pde4 | |
NZ543867A (en) | Modified fluorinated nucleoside analogues | |
NL300933I2 (nl) | Letermovir | |
AP2005003213A0 (en) | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections. | |
DK1864975T3 (da) | Nikotinamid-derivater anvendelige som P38-inhibitorer | |
NO20050465L (no) | Modifisere 2`- og 3`-nukleosid prodrug for behandling av flaviviridae infeksjoner | |
SE0102438D0 (sv) | New compounds | |
ZA200410290B (en) | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections | |
DK2251015T3 (da) | Modificerede nukleotider til behandling af virusinfektioner og abnorm celleproliferation | |
AP2005003211A0 (en) | 1'-,2'-and 3'-modified nucleoside derivatives for treating flaviviridae infections. | |
MY132106A (en) | New pyridazin-3(2h)-one derivatives | |
AP9901535A0 (en) | Novel 4-Phenylpiperidines for the treatment of pruritic dermatoses. | |
GB0209891D0 (en) | Novel compounds | |
BR0316407A (pt) | Derivados de nucleosìdeo antiviral | |
NO20042676L (no) | 3-beta-d-ribofuranolsyltiazolo[4,5-d]pyrimidinnukleosider og anvendelser derav | |
NO20053115D0 (no) | Fremgangsmate for fremstilling av 2'-forgrenede nukleosider. | |
CR7025A (es) | Derivados biarilicos de nicotinamida de utilidad como inhibidores de isozimas pde4 | |
YU81100A (sh) | Derivati 2-(purin-9-il)tetrahidrofuran-3,4 diola | |
IS7851A (is) | 1-asýl-pýrrólídínafleiður til að meðhöndla veirusýkingar | |
NO20050662L (no) | COX-2 inhiberende pyridinderivater | |
CY1109808T1 (el) | Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α | |
PT1075477E (pt) | Novos n-oxidos de benzonaftiridina | |
WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |